title: Severe toxicity related to a pharmacokinetic interaction between docetaxel and ritonavir in HIV-infected patients.
authors.forename: Olivier
authors.initials: O
authors.lastname: Mir
authors.forename: Bernadette
authors.initials: B
authors.lastname: Dessard-Diana
authors.forename: Agnès Lillo-Le
authors.initials: AL
authors.lastname: Louet
authors.forename: Pierre
authors.initials: P
authors.lastname: Loulergue
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Viard
authors.forename: Anne
authors.initials: A
authors.lastname: Langlois
authors.forename: Catherine
authors.initials: C
authors.lastname: Durdux
authors.forename: Christine
authors.initials: C
authors.lastname: Le Beller
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D000077143:Docetaxel; D004347:Drug Interactions; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D052016:Mucositis / Q000139:chemically induced; D009503:Neutropenia / Q000139:chemically induced*; D019438:Ritonavir / Q000009:adverse effects* / Q000493:pharmacokinetics; D003294:Seizures, Febrile / Q000139:chemically induced; D043823:Taxoids / Q000493:pharmacokinetics*
chemical_list: D000970:Antineoplastic Agents; D017320:HIV Protease Inhibitors; D043823:Taxoids; D000077143:Docetaxel; D019438:Ritonavir